Ramey & Schwaller is a full-service intellectual property law firm working with an international client base from our Houston, Texas office. We are dedicated to enhancing clients results through efficient practice management, innovative technologies and the use of skilled professionals. www.rameyfirm.com
In accordance with the temporary authority provided by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) signed by President Trump on March 27, the United States Patent and Trademark Office (USPTO) today further extended the time to file certain patent and trademark-related documents and to pay certain required fees, which otherwise would have been due between March 27 and May 31, to June 1, 2020. This is in addition to the prior extension the USPTO had announced on March 31, 2020.
“Innovation and entrepreneurship will play a key role in our fight against this pandemic, and in the upcoming recovery of our country,” said Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office. “Accordingly, the USPTO continues to assess measures to support the work of inventors and entrepreneurs during this crisis and beyond.”
For details of the latest extension, read the official Patent and Trademark notices on our website. The USPTO will continue to evaluate the evolving situation around COVID-19 and the impact on the USPTO’s operations and stakeholders.
The new notices supersede the previously posted:
“Notice of Waiver of Patent-Related Timing Deadlines under the Coronavirus Aid, Relief, and Economic Security Act,” dated March 31, 2020;
“Notice of Waiver of Trademark-Related Timing Deadlines under the Coronavirus Aid, Relief, and Economic Security Act,” dated March 31, 2020; and
“Relief Available to Patent and Trademark Applicants, Patentees and Trademark Owners Affected by the Coronavirus Outbreak,” dated March 16, 2020.
The USPTO will also update its answers to the CARES Act Frequently Asked Questions (FAQs) in accordance with these notices.
WASHINGTON — The United States Patent and Trademark Office (USPTO) today announced a new COVID-19 Prioritized Examination Pilot Program.
Under this new pilot program, the USPTO will grant requests for prioritized examination to applicants that qualify for small or micro entity status without payment of the typical fees associated with other prioritized examination. In addition, the USPTO will endeavor to reach final disposition of applications in this program within six months if applicants respond promptly to communications from the USPTO.
“Independent inventors and small businesses are often the difference makers when it comes to cutting-edge innovation and the growth of our economy,” said Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director of the USPTO. “They are also in most need of assistance as we fight this pandemic. Accelerating examination of COVID-19-related patent applications, without additional fees, will permit such innovators to bring important and possibly life-saving treatments to market more quickly.”
To qualify for the new program, the claims of an application must cover a product or process that is subject to U.S. Food and Drug Administration (FDA) approval for use in the prevention and/or treatment of COVID-19. See the Federal Register Notice for more information.
Stay current with the USPTO by subscribing to receive email updates at our Subscription Center at www.uspto.gov/subscribe